Model
Edge
Moonlake Immunotherapeutics
0001920785
Filing Type
4
Filing Date
10/7/2024
Updated
10/8/24, 2:01 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership